Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer
Abstract Although the value of tumor-infiltrating lymphocytes is well known, the clinical relevance of an increased immune response, specifically in breast cancer, has not been investigated across large cohorts of patients using computational algorithms. Our hypothesis stated that an enhanced immune...
Main Authors: | Masanori Oshi, Ankit Patel, Rongrong Wu, Lan Le, Yoshihisa Tokumaru, Akimitsu Yamada, Li Yan, Ryusei Matsuyama, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-022-00466-2 |
Similar Items
-
CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
by: Masanori Oshi, et al.
Published: (2020-09-01) -
Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)
by: Masanori Oshi, et al.
Published: (2020-11-01) -
ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
by: Masanori Oshi, et al.
Published: (2020-09-01) -
A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Masanori Oshi, et al.
Published: (2021-05-01) -
Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer
by: Masanori Oshi, et al.
Published: (2021-03-01)